NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 3051-3075 out of 3510.

<< < 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 > >>

Public Release: 18-Dec-2013
PLOS ONE
No link between HIV-prevention pill Truvada and increased sexual risk behavior
In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention. Led by Gladstone Institutes' Investigator Robert Grant, M.D., M.P.H., this research was hailed as an important step towards reducing the worldwide HIV/AIDS epidemic. Now, a new study provides further proof that regular Truvada use can reduce one's risk for contracting HIV -- without increasing sexual risk behavior.
National Institutes of Health, Bill and Melinda Gates Foundation

Contact: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534
Gladstone Institutes

Public Release: 17-Dec-2013
Stem Cells
Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells
A CU Cancer Center study published today in the journal Stem Cells shows that progenitor cells that create dangerous, muscle-invasive bladder cancer are different than the progenitor cells that create non-muscle invasive bladder cancer. Though these two cancers grow at the same site, they are different diseases.
National Institutes of Health

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 17-Dec-2013
Vaccine
Study: Moderate alcohol consumption boosts body's immune system
Medical science has known for years that people who drink moderate amounts of alcohol actually have a reduced risk of death. Now, new research from Oregon Health & Science University adds a fascinating twist: moderate drinking may actually bolster our immune system and help it fight off infection.
National Institutes of Health, NIH/National Institute on Alcohol Abuse and Alcoholism

Contact: Todd Murphy
murphyt@ohsu.edu
503-494-8231
Oregon Health & Science University

Public Release: 17-Dec-2013
Childhood Obesity
TV ads nutritionally unhealthy for kids, study finds
The nutritional value of food and drinks advertised on children's television programs is worse than food shown in ads during general air time, according to a new study.
US Centers for Disease Control and Prevention, NIH/National Cancer Institute, Robert Wood Johnson Foundation

Contact: Sherri McGinnis Gonzalez
smcginn@uic.edu
312-996-8277
University of Illinois at Chicago

Public Release: 17-Dec-2013
Nature Neuroscience
Silencing synapses
Imagine kicking a cocaine addiction by simply popping a pill that alters the way your brain processes chemical addiction. New research from the University of Pittsburgh suggests that a method of biologically manipulating certain neurocircuits could lead to a pharmacological approach that would weaken post-withdrawal cocaine cravings. The findings have been published in Nature Neuroscience.
National Institutes of Health National Institute on Drug Abuse, German Research Foundation

Contact: Joe Miksch
jmiksch@pitt.edu
412-624-4358
University of Pittsburgh

Public Release: 17-Dec-2013
Journal of the American Chemical Society
Water in cells behaves in complex and intricate ways
In a sort of biological "spooky action at a distance," water in a cell slows down in the tightest confines between proteins and develops the ability to affect other proteins much farther away, University of Michigan researchers have discovered.
National Science Foundation, National Institutes of Health, Camille and Henry Dreyfus Foundation

Contact: Nicole Casal Moore
ncmoore@umich.edu
734-647-7087
University of Michigan

Public Release: 17-Dec-2013
Molecular Cancer Research
Study finds known lung cancer oncogenes ALK and ROS1 also drive colorectal cancer
A University of Colorado Cancer Center study published online ahead of print in the journal Molecular Cancer Research shows that ALK and ROS1 gene rearrangements known to drive subsets of lung cancer are also present in some colorectal cancers. These results imply that drugs used to target ALK and ROS1 in lung cancer may also have applications in this subset of colorectal cancer patients.
NIH/National Cancer Institute

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 17-Dec-2013
Cell Reports
UCLA study challenges long-held hypothesis that iron promotes atherosclerosis
A UCLA research team has found no evidence of an association between iron levels in the body and the risk of atherosclerosis. The discovery, based on a comprehensive study in a mouse model of atherosclerosis, contradicts a long-held hypothesis about the role of iron in the disease and carries important implications for patients with chronic kidney disease or anemia related to inflammatory disorders, many of whom receive high-dose iron supplementation therapy.
National Institutes of Health

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles Health Sciences

Public Release: 17-Dec-2013
Demography
Poor health of Irish immigrants in England may be linked to childhood abuse, study finds
Irish immigrants to England during most of the 20th century generally suffered from poor health, in contrast to the general pattern where immigrants are healthier than the native population. A new study suggests that the troubles were not caused primarily by the difficulties of assimilation or tensions between the two nations, but by the abuse Irish expatriates suffered as children in their homeland.
Fulbright Commission, Center for Health and Wellbeing, NIH/National Institute of Aging

Contact: Warren Robak
robak@rand.org
310-451-6913
RAND Corporation

Public Release: 17-Dec-2013
2013 ASCB Annual Meeting
Researchers explain why some wound infections become chronic
Why does treating chronic wounds cost so much? What complicates chronic wound infections, making healing difficult? Manuela Martins-Green, professor of cell biology at the University of California, Riverside, reports at a meeting in New Orleans today that two biological activities are out of control in chronic wound infections. These are reactive oxygen species, which are chemically reactive molecules formed by the partial reduction of oxygen, and biofilms that are formed by selective invading bacteria.
National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 17-Dec-2013
Journal of Clinical Investigation
Moffitt researchers discover mechanism controlling the development of myelodysplastic
Researchers at the Moffitt Cancer Center have discovered a control mechanism that can trigger the development of myelodysplastic syndromes, a group of blood cancers. This finding may lead to therapies capable of preventing the progression of these diseases.
National Institute of Health, NIH/National Cancer Institute, US Army Medical Research & Materiel Command

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute

Public Release: 17-Dec-2013
Pitt-led network gets $70 million over 7 years to develop, test HIV prevention products
With funding of $70 million to support its effort into 2021, the Microbicide Trials Network will continue to develop and test products that aim to reduce the spread of HIV. The extensive program, based at the University of Pittsburgh and Magee-Womens Research Institute, has completed 13 trials since 2006; 11 more are in progress or will begin within the year; and new studies will be designed and implemented during the next funding period.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences

Public Release: 16-Dec-2013
Brigham and Women's Hospital receives a $140 million NIH grant to fund the AIDS Clinical Trial Group
The National Institute of Allergy and Infectious Diseases has awarded two seven-year grants to Brigham and Women's Hospital to fund the AIDS Clinical Trial Group Network. The grants support the ACTG's Leadership and Operations Center and Laboratory Center. The funding totals $20 million annually or $140 million over seven years.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jessica Maki
jmaki3@partners.org
617-525-6373
Brigham and Women's Hospital

Public Release: 16-Dec-2013
Vaccine
Can a glass of wine a day keep the doctor away?
It's the time of year when many of us celebrate the holidays with festive foods and drinks, including alcohol. No better time then to ask if it's true, as is widely held, that moderate consumption of alcohol is beneficial to health. A UC Riverside-led research team now has data that could put the question to rest. The researchers found that moderate alcohol consumption could bolster our immune system, and potentially our ability to fight infections.
National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 16-Dec-2013
Journal of Neuroscience
U-M tinnitus discovery opens door to possible new treatment avenues
For tens of millions of Americans, a diagnosis of tinnitus means there's no such thing as the sound of silence. Now, new scientific findings may help explain what is going on inside these unquiet ears and brains.
National Institutes of Health, Coulter Translational Research Partnership

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 16-Dec-2013
Proceedings of the National Academy of Sciences
Research shows how household dogs protect against asthma and infection
Children's risk for developing allergies and asthma is reduced when they are exposed in early infancy to a dog in the household, and now researchers have discovered a reason why.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jeffrey Norris
jeffrey.norris@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 16-Dec-2013
American Journal of Gastroenterology
Spurred by food allergies, 2 esophagus conditions stump doctors
Researchers at the UNC School of Medicine found that two on-the-rise esophagus conditions are so similar that even a biopsy is not enough to distinguish one disease from the other.
National Institutes of Health, American College of Gastroenterology

Contact: Mark Derewicz
mark.derewicz@unch.unc.edu
919-923-0959
University of North Carolina Health Care

Public Release: 16-Dec-2013
Mind, Brain and Education
Bedtime for toddlers: Timing is everything, says CU-Boulder study
The bedtime you select for your toddler may be out of sync with his or her internal body clock, which can contribute to difficulties for youngsters attempting to settle in for the night, according to a new University of Colorado Boulder study.
NIH/National Institute of Mental Health

Contact: Monique LeBourgeois
Monique.LeBourgeois@colorado.edu
303-492-4584
University of Colorado at Boulder

Public Release: 16-Dec-2013
Journal of Clinical Investigation
IU cancer researchers: Retinoblastoma dysfunction promotes pancreatic cancer cell growth
Indiana University cancer researchers have discovered that a protein that normally suppresses tumors actually promotes the growth and spread of pancreatic cancer.
National Institutes of Health

Contact: Michael Schug
maschug@iupui.edu
317-278-0953
Indiana University

Public Release: 16-Dec-2013
Immunity
Researchers discover how a protein complex revs up T cell activation to fight infections
St. Jude Children's Research Hospital scientists have identified a protein complex that is essential for jumpstarting the immune response during the critical first 24 hours of an infection. The research appears in the current issue of the scientific journal Immunity. Researchers showed the protein complex mTORC1 helps to ensure that newly activated T cells have the energy necessary to launch proliferation. T cells are white blood cells that fight disease and promote immune system balance.
National Institutes of Health, American Cancer Society

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital

Public Release: 16-Dec-2013
PLOS Pathogens
WSU scientists find burglary-ring-like mechanism in lethal 'Contagion' virus
A team of scientists from Washington State University has discovered how one of the planet's most deadly known viruses employs burglary-ring-like teamwork to infiltrate the human cell. Nipah virus is so menacing that the nation's top infectious disease experts served as consultants in the filmmaking of the 2011 medical thriller, "Contagion," which is based on a global Nipah outbreak.
National Institutes of Health

Contact: Hector Aguilar-Carreno
haguilar@vetmed.wsu.edu
509-335-4410
Washington State University

Public Release: 16-Dec-2013
Nature Genetics
Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models
Amyotrophic lateral sclerosis, better known as Lou Gehrig's disease, is a devastating illness that gradually robs sufferers of muscle strength and eventually causes a lethal, full-body paralysis. Working with a powerful fruit fly model of the disease, University of Pennsylvania researchers and colleagues reduced disease toxicity and slowed the dysfunction of neurons. Their discoveries offer the possibility of a new strategy for treating ALS.
National Institutes of Health, Howard Hughes Medical Institute, Packard Center for Amyotrophic Lateral Sclerosis, and others

Contact: Katherine Unger Baillie
kbaillie@upenn.edu
215-898-9194
University of Pennsylvania

Public Release: 16-Dec-2013
International Journal of General Medicine
Regenstrief and IU investigators identify first biomarker linked to delirium duration
Researchers from the Regenstrief Institute and the Indiana University Center for Aging Research have identified the first biomarker that appears to be linked to the duration of delirium. This novel role for S100-beta as a biomarker for delirium duration in critically ill patients may have important implications for refining future delirium treatment in intensive care unit patients.
NIH/National Institute on Aging, NIH/National Institute of Mental Health

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University

Public Release: 16-Dec-2013
Obesity
Health care costs steadily increase with body mass
According to a study published in the journal Obesity, health care costs increase in parallel with body mass measurements, even beginning at a recommended healthy weight.
Centers for Disease Control, NIH/National Institute for Occupational Safety and Health

Contact: Rachel Harrison
rachel.harrison@duke.edu
919-419-5069
Duke University Medical Center

Public Release: 16-Dec-2013
Icahn School of Medicine at Mount Sinai garners $6 million NIH grant for concussion research
The Brain Injury Research Center of Mount Sinai has received a four-year, $6 million grant to study traumatic brain injuries in civilians.
National Institutes of Health

Contact: Sid Dinsay
sid.dinsay@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Showing releases 3051-3075 out of 3510.

<< < 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.